INVO Bioscience Total Liabilities

INVO Bioscience (INVO) currently reports a total liabilities of $9.6B as of March 2026. That compares with $24B in the prior-year period — down 60.6% year over year. Use the charts on this page to explore INVO Bioscience's total liabilities history and peer comparisons.

INVO Bioscience's total liabilities decreased from $24B to $9.6B — a 60.6% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

INVO Bioscience reported $9.6B in total liabilities as of March 2026. That compares with $24B in the prior-year period — down 60.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $9.6B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for INVO Bioscience, and consider following INVO for alerts when major investors trade the stock.

INVO Bioscience is classified in the Healthcare sector. On total liabilities, it currently shows $9.6B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing INVO with unrelated industries.